InvestorsHub Logo
Followers 22
Posts 3646
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Thursday, 05/09/2024 4:11:39 PM

Thursday, May 09, 2024 4:11:39 PM

Post# of 173
Excellent -

Collegium Reports First Quarter 2024 Financial Results

May 9, 2024

– Generated Q1’24 Net Revenue of $144.9 Million –

– Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up 4.2% Year-over-Year –

– Achieved Q1’24 GAAP Net Income of $27.7 Million vs. Q1’23 GAAP Net Loss of $(17.4) Million –

– Delivered Q1’24 Adjusted EBITDA of $92.4 Million, Up 5% Year-over-Year –

– Board of Directors Authorized $35.0 Million Accelerated Share Repurchase Program –

– Reaffirmed Full-Year 2024 Guidance –

Joe C. to step down as President & C.E.O. -

https://ir.collegiumpharma.com/news-releases/news-release-details/collegium-reports-first-quarter-2024-financial-results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News